Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Discovery of ZN-c3, a Highly Potent and Selective Wee1 Inhibitor Undergoing Evaluation in Clinical T

Journal Article · · J. Med. Chem.
; ; ; ; ; ; ; ; ; ;

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; INDUSTRY
OSTI ID:
1832557
Journal Information:
J. Med. Chem., Vol. 64, Issue (17)
Country of Publication:
United States
Language:
ENGLISH

References (32)

Cell-cycle checkpoints and cancer November 2004
G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer January 2008
Targeting the S and G2 checkpoint to treat cancer March 2012
Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog May 1987
Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1 April 2012
Efficient Induction of Apoptosis by Wee1 Kinase Inhibition in Hepatocellular Carcinoma Cells June 2014
Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets April 2009
A Phase I Clinical Trial of AZD1775 in Combination with Neoadjuvant Weekly Docetaxel and Cisplatin before Definitive Therapy in Head and Neck Squamous Cell Carcinoma March 2018
Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition January 2019
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions October 2014
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer December 2019
High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy June 2012
RNAi screening of the kinome with cytarabine in leukemias March 2012
Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia January 2012
In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma September 2010
Expression and prognostic value of the WEE1 kinase in gliomas January 2016
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma March 2014
Cyclins and cyclin-dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis March 2003
Targeting WEE1 Kinase in Cancer October 2016
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target September 2020
Structure-activity relationships of Wee1 inhibitors: A review October 2020
Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy August 2018
4-Phenylpyrrolo[3,4- c ]carbazole-1,3(2 H ,6 H )-dione Inhibitors of the Checkpoint Kinase Wee1. Structure−Activity Relationships for Chromophore Modification and Phenyl Ring Substitution July 2006
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents November 2009
A WEE1 Inhibitor Analog of AZD1775 Maintains Synergy with Cisplatin and Demonstrates Reduced Single-Agent Cytotoxicity in Medulloblastoma Cells January 2016
KinMap: a web-based tool for interactive navigation through human kinome data January 2017
Structure and Inhibition of the Human Cell Cycle Checkpoint Kinase, Wee1A Kinase April 2005
Synthesis and structure–activity relationships of soluble 8-substituted 4-(2-chlorophenyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of the Wee1 and Chk1 checkpoint kinases February 2008
Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors September 2017
Protein Kinase−Inhibitor Database: Structural Variability of and Inhibitor Interactions with the Protein Kinase P-Loop September 2010
Understanding the Impact of the P-loop Conformation on Kinase Selectivity May 2011
Platform for Ring-Fluorinated Benzoheterole Derivatives: Palladium-Catalyzed Regioselective 1,1-Difluoroallylation and Heck Cyclization January 2016

Similar Records

Related Subjects